The CPEB3 was reported to support the recruitment of regulatory T cells and lowering the recruitment of immune cells with anti-cancer activity in renal carcinoma (Hong et al., 2024), and of anti-inflammatory macrophages in colorectal carcinoma (Zhong et al., 2020). Here, CPEB3 is linked to cancer.